Industrials and support services: sector news on Saturday 24 October 2026
Average tone +3.0 (positive) across 7 companies with relevant coverage, from 21 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| Rentokil Initial | +5.3 | 10 | Coverage was mainly analyst reaction to the Q3 trading update, with UBS raising its price target as North America shows signs of stabilising and Jefferies keeping a Buy rating. |
| Experian | +5.7 | 4 | Coverage leaned positive, led by Experian Health's purchase of eInsights to strengthen its insurance offering. |
| Bunzl | −3.8 | 2 | Coverage was mainly about Jefferies reaffirming its Underperform rating on Bunzl, which weighs on the tone. |
| Compass Group | +2.7 | 2 | Coverage was mainly about Compass Group's upcoming results and its share price and market value. |
| DCC Energy | +1.3 | 1 | Coverage was limited to a light feature on a day in the life at Certas Energy, one of DCC's businesses. |
| Smiths Group | +7.0 | 1 | Coverage centred on Berenberg raising its price target for Smiths to 3,200p, which leans positive. |
| Spirax Group | +3.0 | 1 | Coverage was limited to a report noting Spirax-Sarco shares trading above their 200-day moving average, which leans mildly positive. |
| Croda International | — | 0 | |
| Diploma | — | 0 | |
| Halma | — | 0 | |
| IMI | — | 0 | |
| Intertek | — | 0 | |
| Weir | — | 0 |
Strongest stories in the sector
- +9.2 Experian Health buys eInsights to boost insurance discovery
Experian Health acquires eInsights, expanding its insurance offering. - +9.2 Rentokil's price target raised by UBS as North America shows signs of stabilising
UBS raises target as North America shows stabilising signs. - +8.7 UBS raises Rentokil price target as North Ameri...
UBS target raise on North American stabilisation. - −8.3 Rentokil Initial plc (RTO): North American Weakness Undermines the Thesis
Commentary says North American weakness undermines investment case. - +8.3 UBS raises Rentokil Initial stock price target on Q3 results By Investing.com
UBS raises target following Q3 results. - +7.5 Smiths stock: Insider sells 26,686 shares. Berenberg lifts target for Smiths stock to GBp 3,200.00 - ad-hoc-news.de
Berenberg raises target to 3,200p; insider sale is minor offset. - −7.0 Bunzl's (BNZL) Underperform Rating Reaffirmed at Jefferies Financial Group
Jefferies reaffirms Underperform rating, a negative analyst view of Bunzl. - +5.8 Rentokil Initial (LON:RTO) Stock Keeps "Buy" Rating at Jefferies Financial Group
Jefferies maintains Buy rating, supportive analyst view. - +5.2 Will Experian stock sustain gains amid overbought conditions and persistent buyer dominance?
Share gains and buyer dominance, tempered by overbought warning. - +3.7 Experian (LSE:EXPN) Mortgage Push Draws Focus As Fair Value Debate Builds
Mortgage push draws attention, though fair value debate adds caution. - +3.5 Compass Group stock: November 24 results follow 11.00 percent guidance at Compass Group stock
Results coverage referencing 11% guidance; mildly positive but vague. - +3.3 Chair-linked trust buys 10,881 US-listed shares in Rentokil Initial (NYSE: RTO).
Chair-linked trust buying shares, mild insider confidence signal.
Industrials and support services: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Industrials and support services sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.